NeuroOne Medical Technologies Corp (NMTC)
0.7698
+0.03
(+3.75%)
USD |
NASDAQ |
Dec 24, 16:00
NeuroOne Medical Technologies Cash from Investing (Quarterly): -0.0369M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| SINTX Technologies Inc | -0.031M |
| Nutriband Inc | -0.047M |
| enVVeno Medical Corp | 6.22M |
| Beyond Air Inc | 16.15M |
| CVRx Inc | -0.037M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.667M |
| Cash from Financing (Quarterly) | 2.544M |
| Free Cash Flow | -11.13M |
| Free Cash Flow Per Share (Quarterly) | -0.0907 |
| Free Cash Flow to Equity (Quarterly) | -2.704M |
| Free Cash Flow to Firm (Quarterly) | -2.704M |
| Free Cash Flow Yield | -54.02% |